[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334775-105":59,"doc-detail-334775-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","jmjd6-autoantibodies-as-a-potential-biomarker-for-inflammation-related-diseases","JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases","","Inflammation is tightly linked to cerebrovascular disease, cardiovascular disease, diabetes, and multiple cancers, and is accompanied early by the emergence of autoantibodies. The study identifies Jumonji C-domain-containing 6 (JMJD6) using recombinant cDNA expression cloning and serum IgG reactivity. Elevated serum anti-JMJD6 antibody levels are reported in patients with ischemic stroke, acute myocardial infarction, diabetes mellitus, and cancers versus healthy donors. Antibody levels correlate with inflammatory indicators including C-reactive protein and intima–media thickness, and JMJD6 is strongly expressed in inflamed and malignant esophageal tissues and atherosclerotic plaques, supporting biomarker value.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/jmjd6-autoantibodies-as-a-potential-biomarker-for-inflammation-related-diseases/334775/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/jmjd6-autoantibodies-as-a-potential-biomarker-for-inflammation-related-diseases/334775.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is JMJD6, and how was it identified in this study?","Question",{"text":113,"@type":114},"JMJD6 was identified by serological antigen discovery using recombinant cDNA expression cloning. The approach showed JMJD6 recognition in patient serum IgG.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which patient groups showed elevated anti-JMJD6 antibody levels?",{"text":118,"@type":114},"Elevated serum anti-JMJD6 antibodies were observed in inflammation-related diseases including ischemic stroke, acute myocardial infarction, diabetes mellitus, and cancers compared with healthy donors.",{"name":120,"@type":111,"acceptedAnswer":121},"How are anti-JMJD6 antibody levels related to inflammation markers and clinical outcomes?",{"text":122,"@type":114},"Anti-JMJD6 antibody levels correlated with inflammation indicators such as C-reactive protein and intima–media thickness. For esophageal cancer, better postoperative survival was reported in the JMJD6-Ab-positive group versus the negative group.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334775,1790013145,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nJMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases  \nBo-Shi Zhang 1,2, Xiao-Meng Zhang 2, Masaaki Ito 3, Satoshi Yajima 4, Kimihiko Yoshida 4, Mikiko Ohno 5,6, Eiichiro Nishi 5,6, Hao Wang 2, Shu-Yang Li 1,2, Masaaki Kubota 1,7, Yoichi Yoshida 1,7, Tomoo Matsutani 1, Seiichiro Mine 1,8,9, Toshio Machida 1,9,10, Minoru Takemoto 11,12, Hiroki Yamagata 12, Aiko Hayashi 11, Koutaro Yokote 11, Yoshio Kobayashi 13, Hirotaka Takizawa 14, Hideyuki Kuroda 15, Hideaki Shimada 3,4, Yasuo Iwadate 1 and Takaki Hiwasa 1,2,3,7, *  \nCitation: Zhang, B.-S.; Zhang, X.-M.; Ito, M.; Yajima, S.; Yoshida, K.; Ohno, M.; Nishi, E.; Wang, H.; Li, S.-Y.; Kubota, M.; et al. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases. Int. J. Mol. Sci. 2024, 25, 4935. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25094935  \nAcademic Editors: Antonino Tuttolomondo, Ida Daniela Perrotta and David Della-Morte  \nReceived: 15 March 2024  \nRevised: 15 April 2024  \nAccepted: 29 April 2024  \nPublished: 30 April 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan; [dr.boshizhang@gmail.com](dr.boshizhang@gmail.com) (B.-S.Z.)  \n2 Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan  \n3 Department of Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan; [hideaki.shimada@med.toho-u.ac.jp](hideaki.shimada@med.toho-u.ac.jp) (H.S.)  \n4 Department of Gastroenterological Surgery, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan  \n5 Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan  \n6 Department of Pharmacology, Shiga University of Medical Science, Otsu 520-2192, Japan  \n7 Comprehensive Stroke Center, Chiba University Hospital, Chiba 260-8677, Japan  \n8 Department of Neurological Surgery, Chiba Prefectural Sawara Hospital, Chiba 287-0003, Japan  \n9 Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba 290-0512, Japan  \n10 Department of Neurosurgery, Eastern Chiba Medical Center, Chiba 283-8686, Japan  \n11 Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan  \n12 Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba 286-8686, Japan  \n13 Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan  \n14 Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba 260-0025, Japan  \n15 Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama 340-0203, Japan  \n* [Correspondence: hiwasa_takaki@faculty.chiba-u.jp](Correspondence: hiwasa_takaki@faculty.chiba-u.jp); Tel.: +81-43-226-2802; Fax: +81-43-226-2159  \nAbstract: Inflammation is closely associated with cerebrovascular diseases, cardiovascular diseases, diabetes, and cancers, and it is accompanied by the development of autoantibodies in the early stage of inflammation-related diseases. Hence, it is meaningful to discover novel antibody biomarkers targeting inflammation-related diseases. In this study, Jumonji C-domain-containing 6 (JMJD6) was identified by the serological identification of antigens through recombinant cDNA expression cloning. In particular, JMJD6 is an antigen recognized in serum IgG from patients with unstable angina pectoris (a cardiovascular disease) . Then, the serum antibody le","cbCaigo5kFve6r9m","https://ap.wps.com/l/cbCaigo5kFve6r9m","pdf",3877854,18,"English","# Introduction\n# Abstract\n# Keywords","[{\"question\":\"What is JMJD6, and how was it identified in this study?\",\"answer\":\"JMJD6 was identified by serological antigen discovery using recombinant cDNA expression cloning. The approach showed JMJD6 recognition in patient serum IgG.\"},{\"question\":\"Which patient groups showed elevated anti-JMJD6 antibody levels?\",\"answer\":\"Elevated serum anti-JMJD6 antibodies were observed in inflammation-related diseases including ischemic stroke, acute myocardial infarction, diabetes mellitus, and cancers compared with healthy donors.\"},{\"question\":\"How are anti-JMJD6 antibody levels related to inflammation markers and clinical outcomes?\",\"answer\":\"Anti-JMJD6 antibody levels correlated with inflammation indicators such as C-reactive protein and intima–media thickness. For esophageal cancer, better postoperative survival was reported in the JMJD6-Ab-positive group versus the negative group.\"}]","JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases | PDF",1790008344,45]